Corticobasal Degeneration clinical trials

The registry lists 64 studies for Corticobasal Degeneration across more than 10 countries. 26 are recruiting or about to start. 11 of them are mainly about Corticobasal Degeneration (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Corticobasal Degeneration studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 25
Recruiting: 21
Active, not recruiting: 6
Status unknown: 5
Not yet recruiting: 3
Enrolling by invitation: 2

Phase

Phase 2: 6
Phase 1: 4
Phase 3: 1
Early Phase 1: 1

Where

United States: 37
Canada: 7
United Kingdom: 6
Italy: 4
France: 3
China: 2

Who runs them

University of California, San Francisco (6) · University of California, Los Angeles (2) · BioSensics (2) · University of Colorado, Denver (2) · National Institute of Neurological Disorders and Stroke (NINDS) (2) · Skane University Hospital (2) · University of Pennsylvania (2) · Massachusetts General Hospital (2)

What is being tested here

Drugs under test in Corticobasal Degeneration studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
NIO752	1	0	1
Nicotinamide-beta-riboside	1	0	1
Glycerol phenylbutyrate	0	0	1
Lithium	0	0	1
Pimavanserin	0	1	1
Flortaucipir	0	0	1
TPI-287	0	0	1
Davunetide	0	0	1
Fasudil	0	0	1

Coming up

0phase 3 studies under way

7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Nov 2026Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling · University Health Network, Toronto
Dec 2026Diagnosing Frontotemporal Lobar Degeneration · University Health Network, Toronto
Dec 2026AI-Enhanced Optimization of Acute Levodopa Challenge Test · Beijing Tiantan Hospital
Feb 2027Scrambler Therapy for Corticobasal Syndrome-Associated Pain · Johns Hopkins University
Jun 2027Music and Brain Stimulation for Upper Extremity Performance in Patients With Corticobasal Syndrome · Johns Hopkins University
Jul 2027Gait Analysis in Neurological Disease · Beth Israel Deaconess Medical Center
Oct 2027Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia · National Institute of Neurological Disorders and Stroke (NINDS)

Who these studies take

Of the 21 Corticobasal Degeneration studies recruiting now, 12 (57%) set no upper age limit and 1 (5%) stop at 75 or younger. 3 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (33%) take healthy volunteers.

Recruiting studies that take each age, of 21
Age	Women	Men
10	3 (14%)	3 (14%)
18	12 (57%)	12 (57%)
30	17 (81%)	17 (81%)
40	19 (90%)	19 (90%)
50	21 (100%)	21 (100%)
65	21 (100%)	21 (100%)
75	21 (100%)	21 (100%)
85	20 (95%)	20 (95%)

Across all 64 studies, recruiting or not: 2% stop at 75 or younger and 0% at 65; 6% take children; 0% are for women only and 0% for men only; 34% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 64. Browse all 64 → or search them.